絞り込み

16260

広告

「duloxetine」の検索結果

2122件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Determination of a clinically important difference and definition of a responder threshold for the UCSD performance-based skills assessment (UPSA) in patients with major depressive disorder.

Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy.

Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline.

Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians.

Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis.

[Objective: The objective of this study was to determine current practices in the Lorraine region in the treatment of neuropathic pain and to assess the challenges faced by general practitioners (GPs).Methods: We conducted a qualitative study by the focus group technique, by constituting a balanced panel of GPs to meet diversification requirements. The number of focus groups was defined to obtain data saturation. The lead author of this study acted as an observer, while a facilitator was responsible for moderating the debate. Analysis of transcripts was performed in two ways: firstly, several readings of the transcripts to highlight the main ideas emerging from these discussions, and secondly, integration of verbatim transcripts in NVivo 10 software to allow complementary computer analysis.Results: The GPs interviewed reported that they prescribed Clonazepam (Rivotril<exposant&#174;), Carbamazepine (Tegretol<exposant&#174;) and Amitriptyline (Laroxyl<exposant&#174;) less often than ten years ago, and Gabapentin (Neurontin<exposant&#174;), Pregabalin (Lyrica<exposant&#174;), Venlafaxin (Effexor<exposant&#174;) and Duloxetine (Cymbalta<exposant&#174;) more often than ten years ago. They reported many difficulties in the daily management of these patients, especially concerning the psychological or psychiatric components associated with this pain, comorbidities, iatrogenic effects, the inefficacy of the available molecules, the difficulties of access to a specialist (including pain centres), acceptance of treatment by patients, limiting requirements (restrictive marketing authorisations, withdrawal of certain products&#8230;).Conclusion].

Evaluation of relative thrombocytopenia, identification of neuropathy, and bleeding risk secondary to utilization of neuromodulating agents in multiple myeloma patients receiving autologous stem cell transplant treated with melphalan, bortezomib, and lenalidomide.

Chemotherapy-induced peripheral neuropathy management.

Impact of Age and Polytherapy on Fingolimod Induced Bradycardia: a Preclinical Study.

DTB Select: 2 | February 2017.

Attentional performance may help to identify duloxetine responders in chronic pain fibromyalgia patients.

Effect of duloxetine on chemotherapy-induced painful peripheral neuropathy.

Investigation of the predictive validity of Laser-EPs on normal, UVB and capsaicin irritated skin with 4 analgesic compounds in healthy volunteers.

Management of peripheral neuropathy induced by chemotherapy in adults with cancer: a review.

Multimodal Analgesia, Current Concepts, and Acute Pain Considerations.

Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI.

An LC-MS/MS method for the simultaneous determination of 15 antipsychotics and two metabolites in hair and its application to rat hair.

Management of fibromyalgia: practical guides from recent evidence-based guidelines.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります